![JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit) | Multidisciplinary Respiratory Medicine | Full Text JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit) | Multidisciplinary Respiratory Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2049-6958-6-4-242/MediaObjects/40248_2011_Article_249_Fig1_HTML.jpg)
JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit) | Multidisciplinary Respiratory Medicine | Full Text
![IJMS | Free Full-Text | Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications IJMS | Free Full-Text | Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications](https://www.mdpi.com/ijms/ijms-23-04573/article_deploy/html/images/ijms-23-04573-g001.png)
IJMS | Free Full-Text | Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications
![Illustration of polycythemia vera, a rare blood cancer with an increase in the number of red blood cells in the body due to mutation in the JAK2 gene. These excess cells thicken Illustration of polycythemia vera, a rare blood cancer with an increase in the number of red blood cells in the body due to mutation in the JAK2 gene. These excess cells thicken](https://c8.alamy.com/comp/2HBA1D4/illustration-of-polycythemia-vera-a-rare-blood-cancer-with-an-increase-in-the-number-of-red-blood-cells-in-the-body-due-to-mutation-in-the-jak2-gene-these-excess-cells-thicken-blood-slowing-its-flow-they-also-cause-complications-such-as-blood-clots-which-can-lead-to-a-heart-attack-or-stroke-without-treatment-polycythemia-vera-can-be-life-threatening-medical-care-can-help-ease-signs-symptoms-and-complications-of-this-disease-over-time-in-some-cases-theres-a-risk-of-progressing-to-more-serious-blood-cancers-such-as-myelofibrosis-or-acute-leukemia-2HBA1D4.jpg)
Illustration of polycythemia vera, a rare blood cancer with an increase in the number of red blood cells in the body due to mutation in the JAK2 gene. These excess cells thicken
![A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications | Leukemia A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2010.148/MediaObjects/41375_2010_Article_BFleu2010148_Fig1_HTML.jpg)
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications | Leukemia
![JAK2 and MPL Mutation Screening: What Are the Indications and How to Interpret the Results - The ASCO Post JAK2 and MPL Mutation Screening: What Are the Indications and How to Interpret the Results - The ASCO Post](https://ascopost.com/media/154872/3.3.46_table.jpg)
JAK2 and MPL Mutation Screening: What Are the Indications and How to Interpret the Results - The ASCO Post
![Distribution of driver mutations in polycythemia vera (PV), essential... | Download Scientific Diagram Distribution of driver mutations in polycythemia vera (PV), essential... | Download Scientific Diagram](https://www.researchgate.net/publication/310394005/figure/fig1/AS:614021959020544@1523405651147/Distribution-of-driver-mutations-in-polycythemia-vera-PV-essential-thrombocythemia.png)